A Role for Mitochondria in NLRP3 Inflammasome Activation

Overview

Journal Nature

Specialty Science

Date 2010 Dec 3

PMID 21124315

Citations 2619

Authors

Rongbin Zhou

Amir S Yazdi

Philippe Menu

Jurg Tschopp

Affiliations

Soon will be listed here.

Abstract

An inflammatory response initiated by the NLRP3 inflammasome is triggered by a variety of situations of host 'danger', including infection and metabolic dysregulation. Previous studies suggested that NLRP3 inflammasome activity is negatively regulated by autophagy and positively regulated by reactive oxygen species (ROS) derived from an uncharacterized organelle. Here we show that mitophagy/autophagy blockade leads to the accumulation of damaged, ROS-generating mitochondria, and this in turn activates the NLRP3 inflammasome. Resting NLRP3 localizes to endoplasmic reticulum structures, whereas on inflammasome activation both NLRP3 and its adaptor ASC redistribute to the perinuclear space where they co-localize with endoplasmic reticulum and mitochondria organelle clusters. Notably, both ROS generation and inflammasome activation are suppressed when mitochondrial activity is dysregulated by inhibition of the voltage-dependent anion channel. This indicates that NLRP3 inflammasome senses mitochondrial dysfunction and may explain the frequent association of mitochondrial damage with inflammatory diseases.

Citing Articles

Electron Microscopy to Visualize and Quantify Mitochondrial Structure and Organellar Interactions in Cultured Cells During Senescence.

Glytsou C Methods Mol Biol. 2025; 2906:229-242.

PMID: 40082359 DOI: 10.1007/978-1-0716-4426-3_13.

NLRP3 inflammasome in cardiovascular diseases: an update.

Mo B, Ding Y, Ji Q Front Immunol. 2025; 16:1550226.

PMID: 40079000 PMC: 11896874. DOI: 10.3389/fimmu.2025.1550226.

TBK1 and IKKε prevent premature cell death by limiting the activity of both RIPK1 and NLRP3 death pathways.

Fischer F, Demarco B, Min F, Yeap H, De Nardo D, Chen K Sci Adv. 2025; 11(10):eadq1047.

PMID: 40053580 PMC: 11887814. DOI: 10.1126/sciadv.adq1047.

Exploring NLRP3-related phenotypic fingerprints in human macrophages using Cell Painting assay.

Herring M, Sarndahl E, Kotlyar O, Scherbak N, Engwall M, Karlsson R iScience. 2025; 28(3):111961.

PMID: 40040812 PMC: 11876907. DOI: 10.1016/j.isci.2025.111961.

Gas6 induces AIM to suppress acute lung injury in mice by inhibiting NLRP3 inflammasome activation and inducing autophagy.

Jeong S, Yang K, Lee Y, Park J, Park E, Kang J Front Immunol. 2025; 16:1523166.

PMID: 40034700 PMC: 11873840. DOI: 10.3389/fimmu.2025.1523166.

References

Veal E, Day A, Morgan B . Hydrogen peroxide sensing and signaling. Mol Cell. 2007; 26(1):1-14. DOI: 10.1016/j.molcel.2007.03.016. View

Hayashi T, Rizzuto R, Hajnoczky G, Su T . MAM: more than just a housekeeper. Trends Cell Biol. 2009; 19(2):81-8. PMC: 2750097. DOI: 10.1016/j.tcb.2008.12.002. View

Moore C, Bergstralh D, Duncan J, Lei Y, Morrison T, Zimmermann A . NLRX1 is a regulator of mitochondrial antiviral immunity. Nature. 2008; 451(7178):573-7. DOI: 10.1038/nature06501. View

Mariathasan S, Newton K, Monack D, Vucic D, French D, Lee W . Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature. 2004; 430(6996):213-8. DOI: 10.1038/nature02664. View

Tattoli I, Carneiro L, Jehanno M, Magalhaes J, Shu Y, Philpott D . NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-kappaB and JNK pathways by inducing reactive oxygen species production. EMBO Rep. 2008; 9(3):293-300. PMC: 2267388. DOI: 10.1038/sj.embor.7401161. View

Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J . Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol. 2009; 11(2):136-40. DOI: 10.1038/ni.1831. View

Brookes P, Yoon Y, Robotham J, Anders M, Sheu S . Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol. 2004; 287(4):C817-33. DOI: 10.1152/ajpcell.00139.2004. View

Latz E . NOX-free inflammasome activation. Blood. 2010; 116(9):1393-4. DOI: 10.1182/blood-2010-06-287342. View

Kastner D, Aksentijevich I, Goldbach-Mansky R . Autoinflammatory disease reloaded: a clinical perspective. Cell. 2010; 140(6):784-90. PMC: 3541025. DOI: 10.1016/j.cell.2010.03.002. View

10.

Restivo N, Srivastava M, Schafer I, Hoppel C . Mitochondrial dysfunction in a patient with crohn disease: possible role in pathogenesis. J Pediatr Gastroenterol Nutr. 2004; 38(5):534-8. DOI: 10.1097/00005176-200405000-00014. View

11.

Latz E . The inflammasomes: mechanisms of activation and function. Curr Opin Immunol. 2010; 22(1):28-33. PMC: 2844336. DOI: 10.1016/j.coi.2009.12.004. View

12.

Franchi L, Munoz-Planillo R, Reimer T, Eigenbrod T, Nunez G . Inflammasomes as microbial sensors. Eur J Immunol. 2010; 40(3):611-5. DOI: 10.1002/eji.200940180. View

13.

Saitoh T, Fujita N, Jang M, Uematsu S, Yang B, Satoh T . Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature. 2008; 456(7219):264-8. DOI: 10.1038/nature07383. View

14.

Yamagata H, Shimizu S, Nishida Y, Watanabe Y, Craigen W, Tsujimoto Y . Requirement of voltage-dependent anion channel 2 for pro-apoptotic activity of Bax. Oncogene. 2009; 28(40):3563-72. DOI: 10.1038/onc.2009.213. View

15.

Domen J, Cheshier S, Weissman I . The role of apoptosis in the regulation of hematopoietic stem cells: Overexpression of Bcl-2 increases both their number and repopulation potential. J Exp Med. 2000; 191(2):253-64. PMC: 2195763. DOI: 10.1084/jem.191.2.253. View

16.

Didierlaurent A, Brissoni B, Velin D, Aebi N, Tardivel A, Kaslin E . Tollip regulates proinflammatory responses to interleukin-1 and lipopolysaccharide. Mol Cell Biol. 2006; 26(3):735-42. PMC: 1347014. DOI: 10.1128/MCB.26.3.735-742.2006. View

17.

Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J . Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006; 440(7081):237-41. DOI: 10.1038/nature04516. View

18.

Schroder K, Tschopp J . The inflammasomes. Cell. 2010; 140(6):821-32. DOI: 10.1016/j.cell.2010.01.040. View

19.

Levine B, Kroemer G . Autophagy in the pathogenesis of disease. Cell. 2008; 132(1):27-42. PMC: 2696814. DOI: 10.1016/j.cell.2007.12.018. View

20.

Oliveira J . Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum. J Neurochem. 2010; 114(1):1-12. DOI: 10.1111/j.1471-4159.2010.06741.x. View